IN181699B - - Google Patents

Info

Publication number
IN181699B
IN181699B IN589DE1994A IN181699B IN 181699 B IN181699 B IN 181699B IN 589DE1994 A IN589DE1994 A IN 589DE1994A IN 181699 B IN181699 B IN 181699B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Jag Mohan Khanna
Naresh Kumar
Brij Khera
Mahavir Singh Khanna
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Priority to IN589DE1994 priority Critical patent/IN181699B/en
Priority to US08/265,307 priority patent/US5621120A/en
Priority to NZ272054A priority patent/NZ272054A/xx
Priority to ZA953682A priority patent/ZA953682B/xx
Priority to AU17983/95A priority patent/AU695181B2/en
Priority to MYPI95001266A priority patent/MY130559A/en
Priority to IN1170DE1997 priority patent/IN184737B/en
Publication of IN181699B publication Critical patent/IN181699B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Furan Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IN589DE1994 1994-05-13 1994-05-13 IN181699B (cs)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IN589DE1994 IN181699B (cs) 1994-05-13 1994-05-13
US08/265,307 US5621120A (en) 1994-05-13 1994-06-24 Process for the manufacture of form 1 ranitidine hydrochloride
NZ272054A NZ272054A (en) 1994-05-13 1995-05-02 Process for producing form 1 ranitidine hydrochloride
ZA953682A ZA953682B (en) 1994-05-13 1995-05-08 Process for the manufacture of Form 1 ranitidine hydrochloride
AU17983/95A AU695181B2 (en) 1994-05-13 1995-05-10 Process for the manufacture of form 1 ranitidine hydrochloride
MYPI95001266A MY130559A (en) 1994-05-13 1995-05-12 Process for the manufacture of form 1 ranitidine hydrochloride
IN1170DE1997 IN184737B (cs) 1994-05-13 1997-05-06

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN589DE1994 IN181699B (cs) 1994-05-13 1994-05-13

Publications (1)

Publication Number Publication Date
IN181699B true IN181699B (cs) 1998-09-05

Family

ID=11090445

Family Applications (2)

Application Number Title Priority Date Filing Date
IN589DE1994 IN181699B (cs) 1994-05-13 1994-05-13
IN1170DE1997 IN184737B (cs) 1994-05-13 1997-05-06

Family Applications After (1)

Application Number Title Priority Date Filing Date
IN1170DE1997 IN184737B (cs) 1994-05-13 1997-05-06

Country Status (4)

Country Link
US (1) US5621120A (cs)
IN (2) IN181699B (cs)
MY (1) MY130559A (cs)
ZA (1) ZA953682B (cs)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020151729A1 (en) * 1997-02-26 2002-10-17 Cheng Wen J. Novel process for the preparation of form 1 ranitidine hydrochloride
USRE43932E1 (en) 1997-07-18 2013-01-15 Novartis Ag Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
EP2266579A1 (en) 2004-10-19 2010-12-29 Achillion Pharmaceuticals, Inc. Pharmaceutical composition comprising elvucitavine
CN106432149B (zh) * 2015-05-26 2018-04-17 烟台市华文欣欣医药科技有限公司 一种制备治疗胃病的药物盐酸雷尼替丁化合物的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
US5338871A (en) * 1991-12-20 1994-08-16 Torcan Chemical Ltd. Preparation of form 1 ranitidine hydrochloride

Also Published As

Publication number Publication date
ZA953682B (en) 1996-01-15
IN184737B (cs) 2000-09-23
MY130559A (en) 2007-06-29
US5621120A (en) 1997-04-15

Similar Documents

Publication Publication Date Title
TW283682B (cs)
TW273635B (cs)
TW286276B (cs)
TW283274B (cs)
BRPI9507160A (cs)
EP0671407A3 (cs)
EP0669187A3 (cs)
EP0665261A3 (cs)
EP0672396A3 (cs)
EP0671446A3 (cs)
EP0670326A3 (cs)
BR9509661A (cs)
TW283264B (cs)
FR2727464B1 (cs)
IN184737B (cs)
FR2723067B1 (cs)
TW284728B (cs)
IN189461B (cs)
FR2728297B1 (cs)
ITMI952511A0 (cs)
BRPI9401073A2 (cs)
IN180719B (cs)
IN180156B (cs)
IN187573B (cs)
EP0669619A3 (cs)